EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Comparative study of anti-SARS-CoV-2 receptor-binding domain total antibody titer before and after heterologous booster with mRNA-based COVID-19 vaccine

Qatrunnada Kamil, Widia Putri, Arianisah P Ayulinda, Imelda Maelani, Samsul Anwar, Ichsan Ichsan, Agung Pranata, Mudatsir Mudatsir, Maimun Syukri, Samsul Rizal, Razali Razali, Hamdani Hamdani und 4 weitere

Narra J · 2024

DOI: 10.52225/narra.v4i3.788 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Narra J, 2024. Verfasst von Qatrunnada Kamil und 15 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia. Hauptthemen laut MEDLINE: Immunization, Secondary, Antibodies, Viral, COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The waning immunity following the COVID-19 vaccination become a significant concern and the immunological dynamics of vaccine-induced antibodies after vaccination need to be explored. The aim of this study was to compare anti-SARS-CoV-2 receptor-binding domain (RBD) antibody levels before and after a booster dose with heterologous COVID-19 vaccine and to identify factors influencing the levels after receiving the booster dose. A cross-sectional study was conducted in which individuals who received primary doses of CoronaVac and a booster dose with an mRNA-based vaccine were recruited using a purposive sampling technique. The titers of anti-SARS-CoV-2 RBD antibodies were measured using an enzyme-linked immunosorbent assay (ELISA), and plausible associated factors were collected using a questionnaire-assisted face-to-face interview. The Wilcoxon test was used to compare the titers before and after the booster dose, while the Kruskal-Wallis and Mann-Whitney tests, followed by multivariate linear regression, were used to assess the factors associated with RBD total antibody titers. The results showed that there was a significant increase of anti-SARS-CoV-2 RBD total antibody titers before and after receiving the booster dose (1,558.7 BAU/mL vs 140.6 BAU/mL, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunization, SecondaryAntibodies, ViralCOVID-19 VaccinesCOVID-19SARS-CoV-2HumansMaleFemaleCross-Sectional StudiesMiddle AgedAdultAgedVaccines, Synthetic

Stichwörter der Autor:innen

Anti-SARS-CoV-2 receptor-binding domain total antibodyCOVID-19booster vaccineheterologous vaccinemRNA vaccine

Substanzen

Antibodies, ViralCOVID-19 VaccinesVaccines, Synthetic

Autor:innen und Institutionen

  • Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
  • Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Banda Aceh, Indonesia.
  • Department of Statistics, Faculty of Mathematics and Natural Science, Universitas Syiah Kuala, Banda Aceh, Indonesia.
  • Department of Microbiology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
  • Tropical Disease Centre, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
  • Tsunami and Disaster Mitigation Research Center (TDMRC), Universitas Syiah Kuala, Banda Aceh, Indonesia.

Zitieren

APA

Kamil, Q., Putri, W., Ayulinda, A. P., Maelani, I., Anwar, S., Ichsan, I., Pranata, A., Mudatsir, M., Syukri, M., Rizal, S., Razali, R., Hamdani, H., Kurniawan, R., Irwansyah, I., Sofyan, S. E., & Harapan, H. (2024). Comparative study of anti-SARS-CoV-2 receptor-binding domain total antibody titer before and after heterologous booster with mRNA-based COVID-19 vaccine. Narra J. https://doi.org/10.52225/narra.v4i3.788

Vancouver

Kamil Q, Putri W, Ayulinda AP, Maelani I, Anwar S, Ichsan I, et al. Comparative study of anti-SARS-CoV-2 receptor-binding domain total antibody titer before and after heterologous booster with mRNA-based COVID-19 vaccine. Narra J. 2024. doi:10.52225/narra.v4i3.788

BibTeX
@article{Kamil2024,
  author = {Kamil, Qatrunnada and Putri, Widia and Ayulinda, Arianisah P and Maelani, Imelda and Anwar, Samsul and Ichsan, Ichsan and Pranata, Agung and Mudatsir, Mudatsir and Syukri, Maimun and Rizal, Samsul and Razali, Razali and Hamdani, Hamdani and Kurniawan, Rudi and Irwansyah, Irwansyah and Sofyan, Sarwo E and Harapan, Harapan},
  title = {Comparative study of anti-SARS-CoV-2 receptor-binding domain total antibody titer before and after heterologous booster with mRNA-based COVID-19 vaccine},
  journal = {Narra J},
  year = {2024},
  doi = {10.52225/narra.v4i3.788}
}
Kostenlos starten →